Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Non-Current Assets: 2015-2019

Historic Non-Current Assets for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $3.6 million.

  • Outlook Therapeutics' Non-Current Assets fell 86.06% to $2.0 million in Q2 2020 from the same period last year, while for Jun 2020 it was $2.0 million, marking a year-over-year decrease of 86.06%. This contributed to the annual value of $3.6 million for FY2019, which is 80.86% down from last year.
  • Per Outlook Therapeutics' latest filing, its Non-Current Assets stood at $3.6 million for FY2019, which was down 80.86% from $19.0 million recorded in FY2018.
  • Outlook Therapeutics' Non-Current Assets' 5-year high stood at $19.8 million during FY2015, with a 5-year trough of $3.6 million in FY2019.
  • Over the past 3 years, Outlook Therapeutics' median Non-Current Assets value was $16.8 million (recorded in 2017), while the average stood at $13.1 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first grew by 12.79% in 2018, then tumbled by 80.86% in 2019.
  • Over the past 5 years, Outlook Therapeutics' Non-Current Assets (Yearly) stood at $19.8 million in 2015, then fell by 0.59% to $19.7 million in 2016, then decreased by 14.69% to $16.8 million in 2017, then climbed by 12.79% to $19.0 million in 2018, then plummeted by 80.86% to $3.6 million in 2019.